Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells. - Wikidata - wikimedia - TriplyDB

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

http://www.wikidata.org/entity/Q39643971

about

Recurrent rearrangements in prostate cancer: causes and therapeutic potential Oncolytic adenovirus-mediated therapy for prostate cancer The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.Evaluating translocation gene fusions by SNP array data.Androgen receptor and its splice variants in prostate cancer Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer Early human prostate adenocarcinomas harbor androgen-independent cancer cells Androgen receptor signaling in prostate cancer development and progression.Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer Hormones and prostate carcinogenesis: Androgens and estrogens.Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.Perspectives on treatment of metastatic castration-resistant prostate cancer.Common gene rearrangements in prostate cancer ETS rearrangements in prostate cancer Molecular pathogenesis and progression of prostate cancer Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: the best and the worst.The complexity of prostate cancer: genomic alterations and heterogeneity.TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression Transcriptional network of androgen receptor in prostate cancer progression.Retinoid receptor signaling and autophagy in acute promyelocytic leukemia.Topoisomerase-mediated chromosomal break repair: an emerging player in many games.The oncogene ERG: a key factor in prostate cancer.Development of enzalutamide for metastatic castration-resistant prostate cancer.Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth.TMPRSS2-ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-analysis of Racial Differences.Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status.

P2860

Q26851525-31DDF8A4-4862-449C-926C-15894EBD806B Q27004796-B2A39D16-AD74-4FD0-9765-F163A5A7D5EC Q27014101-155596D3-5341-4B3F-B438-948D7EC46A3F Q28687241-122E8A65-45AF-4FBE-829D-4243619DADE8 Q33831390-568E86E3-E259-40ED-A602-4D5C8E32F964 Q34132911-A68E754D-F1E7-4759-866E-4A012F80F4FD Q34199684-90AC3EB9-B350-4B30-ACD1-AE8AE9451968 Q34287725-15471977-9E31-4BA7-BE97-113DAF1BC50A Q34525129-A05158C6-61CE-413D-9D26-DD6B7B02693C Q34704983-ADF930F7-05CA-422E-A052-7AD140BD8F08 Q35005020-93809D5C-EFC3-4711-9B6F-8A93D2D2D771 Q35183663-38BD78A8-1558-4575-A07E-98C53EECC86A Q35199287-AE5F8593-61AD-4D3E-BA42-1DBEC535D96A Q35535396-F1ACA598-7330-482A-B51B-487993F2BD35 Q35554127-853DA931-7986-4D05-8427-DEB5591D2DD2 Q35582540-C80F4CC0-D5A4-4DE6-8A07-4998564A4509 Q35687198-84D011E8-993A-4921-BFED-F30C8AF8A239 Q36758880-386E25CD-EEE4-4BBC-9828-4DF8B44E9B15 Q36871685-A2294037-9144-4ABB-B11A-4D1DDB04F028 Q36920169-93EEB30A-F646-4A6C-A7D1-8078AAC7EAA5 Q37047029-8150507A-2594-40F8-9202-17442F687137 Q37055715-E5FBF3A3-1B1E-447E-833F-C8CA31CF036C Q37174726-05486133-341A-4953-BDF2-0A5486A133F0 Q37285569-0998F5AD-509E-4BB3-96BC-967672054EC6 Q37727814-F5AF4DC5-1A0D-4F4C-8EEC-3A98ACACC8D2 Q37947091-4D77BF19-B78C-42F7-88F2-99EB10CC5001 Q37972706-2DF9C247-460F-4ADB-A202-615ACC1BA7E9 Q38023979-F377BB68-4D2A-4C0E-9C68-E36A2E666D0B Q38058243-5BEE2B39-86AB-4482-A820-7ECCDA3BCC1D Q38069582-BC9606E2-0775-4132-8146-E4A063B442D0 Q38100269-7C9EFAB7-88D8-468A-AB02-A06825C4F071 Q38201532-EF5CF37A-4948-4D13-B2C3-293151427E93 Q38360744-2831A4F8-A763-489F-93F6-FE036DA71CEC Q38444138-FE4FC064-5523-47B3-83CD-9F436F770E69 Q38589130-52A8DFC2-0A8C-4061-85A1-2472D7B33D38 Q38820055-E55D30FE-2568-4F35-B49C-F3A17A794252 Q38874548-FA7656C4-C90B-40DC-B929-74680C0FF0CC Q38969070-D9879854-EB41-4806-9384-C5F6432BBBA4 Q39386421-3AF7F561-FB9A-4BDE-B514-0B0BB7122F7A Q42028012-2E4B335B-DFE6-4AE7-96F1-005F1ABC5945

P2860

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

http://www.wikidata.org/entity/Q39643971

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

@en

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

@nl

type

label

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

@en

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

@nl

prefLabel

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

@en

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

@nl

P1433

Q39643971-743E6B58-382E-4F02-9E4C-5DD4BECFD4E8

P1476

Q39643971-E927963B-C81B-45A7-89DA-7E02857A59EB

P2093

Q39643971-121FB842-E221-47CC-840A-EFD0BCD7F68D

Q39643971-1DAA8BB5-67E2-428F-83CB-EC27BF028F72

Q39643971-227CD125-A81E-4175-AE0F-56B53C6C116D

Q39643971-764FB00C-2762-48F9-B5E4-7B34EB4FFB4B

Q39643971-BEF10CFD-B921-44B4-8C27-4224ECB1C0A7

Q39643971-C2524928-A727-4243-910C-C4F1EB68EF3F

P2860

Q39643971-016BB3CE-5DA3-4A5B-BD19-708B694F2132

Q39643971-06A515F2-BD4C-430F-84BE-8D696F536D5D

Q39643971-09F84162-F688-4E40-A1E3-88E4AF8CC395

Q39643971-205A5DDC-1BAE-45B8-83CA-27831F33EF1F

Q39643971-2F7DF9EA-4AA4-48D0-A06E-4174AE362FF0

Q39643971-43C328AE-221E-4CFF-ABA8-7F4DFE168609

Q39643971-48306D1C-8EF8-42B8-B32F-70D8DE84C0EA

Q39643971-73DD9BE5-C62E-42F6-A8F3-B59481DB9251

Q39643971-7BC2041C-2F52-49AF-987D-E4C68EB31327

Q39643971-80AAD72D-193F-490B-B6DA-9FEFBFD47716

P304

Q39643971-9CE1A156-A6C3-4158-A45B-25C88EBF2954

P31

Q39643971-3FD045A0-67B6-4568-8ED8-B07333FBE260

P356

Q39643971-07F0D252-61C6-4BE9-A319-DE696EF616EB

P407

Q39643971-B8C3F45E-4859-4292-938B-EF379DEB8882

P433

Q39643971-FF2F5E7B-A081-49A0-BE31-D669C5E71D6F

P478

Q39643971-73F265BC-08C6-4317-B506-AE349539AB19

P50

Q39643971-276CBBB7-587D-45C6-9AF6-EB43013A2CDD

Q39643971-F3F4F78A-E96E-4CAB-94E3-D718CB765747

P577

Q39643971-58C87206-F967-4518-A336-F92BADF6C8BB

P698

Q39643971-256E863F-F754-4E46-B36C-D062B6743547

P932

Q39643971-9B317EE0-7469-4127-886F-F0A27D54CAE4

P356

0008-5472.CAN-10-1638

P1433

Cancer Research

P1476

Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells

@en

P2093

Elzbieta Stankiewicz

http://www.w3.org/2001/XMLSchema#string

Lara K Boyd

http://www.w3.org/2001/XMLSchema#string

Nuria Coll Bastus

http://www.w3.org/2001/XMLSchema#string

R Tim D Oliver

http://www.w3.org/2001/XMLSchema#string

Sakunthala C Kudahetti

http://www.w3.org/2001/XMLSchema#string

Xueying Mao

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Myc dynamically and preferentially relocates to a transcription factory occupied by Igh

Induced chromosomal proximity and gene fusions in prostate cancer.

Origins of chromosome translocations in childhood leukaemia.

Spatial genome organization in the formation of chromosomal translocations

The impact of translocations and gene fusions on cancer causation.

Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules

Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.

Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer.

Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.

P304

9544-9548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-1638

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20947519

http://www.w3.org/2001/XMLSchema#string

P932

3000385

http://www.w3.org/2001/XMLSchema#string